BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19583)

  • 1. Potentiation by reserpine of the inhibition by amphetamine of (3H)dopamine accumulation in the rat striatum.
    Ross SB
    J Pharm Pharmacol; 1977 Jul; 29(7):433-4. PubMed ID: 19583
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of (+)-amphetamine on the retention of 3H-catecholamines in slices of normal and reserpinized rat brain and heart.
    Ross SB; Renyi AL
    Acta Pharmacol Toxicol (Copenh); 1978 May; 42(5):328-36. PubMed ID: 581027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of neuroleptics and of combinations of d-amphetamine and neuroleptics on 3H-dopamine uptake by homogenates from rat striatum.
    Del Rio J; Madroñal J
    Eur J Pharmacol; 1976 Oct; 39(2):267-74. PubMed ID: 976322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3H]Dopamine release by d-amphetamine from striatal synaptosomes of reserpinized rats.
    Masuoka DT; Alcaraz AF; Schott HF
    Biochem Pharmacol; 1982 Jun; 31(11):1969-74. PubMed ID: 7115417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphetamine induced release of endogenous dopamine in vitro is not reduced following pretreatment with reserpine.
    Niddam R; Arbilla S; Scatton B; Dennis T; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Apr; 329(2):123-7. PubMed ID: 4010791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H]dopamine depletion from osmotically defined storage sites: effects of reserpine, 53 mM KCl, and d-amphetamine.
    Takimoto GS; Stittsworth JD; Stephens JK
    J Neurochem; 1983 Jul; 41(1):119-27. PubMed ID: 6864214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release of dopamine from central noradrenaline nerves after treatment with reserpine plus amphetamine.
    Andén NE; Svensson TH
    J Neural Transm; 1973; 34(1):23-30. PubMed ID: 4714591
    [No Abstract]   [Full Text] [Related]  

  • 8. One injection of cocaine produces a long-lasting increase in [3H]-dopamine release.
    Peris J; Zahniser NR
    Pharmacol Biochem Behav; 1987 Jul; 27(3):533-5. PubMed ID: 3659076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition by d-amphetamine of the electrically evoked release of [3H]acetylcholine from slices of the rat striatum: involvement of dopamine receptors.
    Cantrill RC; Arbilla S; Langer SZ
    Eur J Pharmacol; 1983 Jan; 87(1):167-8. PubMed ID: 6840186
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of 3H-dopamine accumulation in reserpinized and normal rat striatum.
    Ross SB; Kelder D
    Acta Pharmacol Toxicol (Copenh); 1979 May; 44(5):329-35. PubMed ID: 474143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phencyclidine-induced release of [3H]dopamine from chopped striatal tissue.
    Ary TE; Komiskey HL
    Neuropharmacology; 1982 Jul; 21(7):639-45. PubMed ID: 7121737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of monoamine oxidase inhibition on the release of 3H-dopamine elicited by potassium and by amphetamine from the rat substantia nigra and corpus striatum.
    Arbilla S; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Feb; 311(1):45-52. PubMed ID: 7366741
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of amphetamines on the metabolism of catecholamines in the rat brain.
    Baldessarini RJ; Harris JE
    J Psychiatr Res; 1974; 11():41-3. PubMed ID: 4477777
    [No Abstract]   [Full Text] [Related]  

  • 14. Reserpine-induced reduction of in vivo binding of SCH 23390 and N-methylspiperone and its reversal by d-amphetamine.
    Inoue O; Tsukada H; Yonezawa H; Suhara T; Langstrom B
    Eur J Pharmacol; 1991 May; 197(2-3):143-9. PubMed ID: 1915566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for carrier-mediated efflux of dopamine from corpus striatum.
    Liang NY; Rutledge CO
    Biochem Pharmacol; 1982 Aug; 31(15):2479-84. PubMed ID: 7126258
    [No Abstract]   [Full Text] [Related]  

  • 16. Uptake of (3H)-catecholamines by homogenates of rat corpus striatum and cerebral cortex: effects of amphetamine analogues.
    Harris JE; Baldessarini RJ
    Neuropharmacology; 1973 Jul; 12(7):669-79. PubMed ID: 4730376
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of psychotropic drugs on the distribution of 3H-dopamine into compartments of rat striatal synaptosomes and on subsequent depolarization-induced 3H-dopamine release.
    de Langen CD; Mulder AH
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Mar; 311(2):169-77. PubMed ID: 7383166
    [No Abstract]   [Full Text] [Related]  

  • 18. Calcium-independent release of [3H]dopamine by veratridine in pargyline- and reserpine-treated corpus striatum.
    Liang NY; Rutledge CO
    Eur J Pharmacol; 1983 Apr; 89(1-2):153-5. PubMed ID: 6861884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of D- and L-amphetamine and methylphenidate on rat striatal dopamine biosynthesis.
    Kuczenski R; Segal DS
    Eur J Pharmacol; 1975 Feb; 30(2):244-51. PubMed ID: 1126362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of vesicular and cytosolic dopamine to the increased striatal dopamine efflux elicited by intrastriatal injection of dexamphetamine.
    Watanabe S; Aono Y; Fusa K; Takada K; Saigusa T; Koshikawa N; Cools AR
    Neuroscience; 2005; 136(1):251-7. PubMed ID: 16181742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.